MIT CEO
June 17 - 18, 2025
Koch Institute at MIT
In order to further cultivate biomedical innovation and the advancement of medicines to help patients, Longwood Healthcare Leaders is gathering thought leaders across pharma, biotech, government, academia, healthcare, and investing for two days of discussion and networking. Join us June 17-18 for this not-to-be missed event at MIT’s Koch Institute.
Longwood Healthcare Leaders MIT CEO is co-hosted with
Sally Kornbluth (President, MIT), Nobelist Phil Sharp (co-founder Biogen/Alnylam), Bob Langer (co-founder Moderna/Momenta), and Matthew Vander Heiden (Director, Koch Institute).
.jpg)
Highlights from last year's MIT CEO
MIT CEO 2024 was hosted at the Koch Institute. See testimonials and highlights from speakers and attendees including Nobelist Phil Sharp, Rochelle Walensky (former director, CDC), Dave Reese (CTO, Amgen), Priya Singhal (EVP, Development, Biogen), Senator Ed Markey, Anne Klibanski (CEO, Mass General Brigham), among others.
Venue
Co-hosted with MIT leadership and held at MIT's Koch Institute in the heart of Cambridge, MA's Kendall Square, MIT CEO
is held at 500 Main Street, Cambridge, MA.
Agenda
Tuesday, June 17
7:00 am
REGISTRATION & NETWORKING BREAKFAST
7:30 am
LONGWOOD FUND INTRODUCTION
Christoph Westphal, General Partner, Longwood Fund
7:45 am
(BIG BIO)PHARMA PIPELINE SOURCING
Bob Bagdorf, Head, WWBD, Pfizer
Nouhad Husseini, SVP, Head, BD & Corporate Strategy, Regeneron
Matthias Müllenbeck, SVP, Head Global Business Development & Alliance Management, EMD Serono
Tarek Rabah, CEO, Otsuka North America
Moderator: Steve Cutler, CEO, ICON
8:15 am
TRANSLATING SCIENCE INTO MEDICINE
Björn Frendéus, CSO, BioInvent
Joe Jimenez, former CEO, Novartis; Managing Director, Aditum Bio
Nello Mainolfi, CEO, Kymera Therapeutics
Brent Vaughan, CEO, Eratos Therapeutics
Moderator: Chen Schor, CEO, Adicet Bio
8:45 am
DRIVING PRODUCTIVITY IN R&D
Ryan Fukushima, CEO, Pathos AI
Oliver Rosen, CMO, Akamis Bio
Lara Sullivan, CEO & CMO, Pyxis Oncology
Richard Wilson, SVP, Primary Focus Lead, Genetic Regulation, Astellas
Moderator: Harvey Berger, CEO, Kojin Therapeutics
9:15 am
ENSURING GLOBAL ACCESS
Ed Boyden, Professor, Brain and Cognitive Sciences and Biological Engineering, MIT
Ryan Richardson, Chief Strategy Officer, BioNTech
Fatima Sabar, CEO, Bluenote
Amanda Wagner, CEO, Immunitas
Moderator: Richard Paulson, CEO, Karyopharm
9:45 am
REGULATORY & INDUSTRY ROUNDTABLE
Jay Bradner, EVP, R&D & CSO, Amgen
Peter Marks, former Director, CBER, FDA
Moderator: Christoph Westphal, General Partner, Longwood Fund
10:10 am
NETWORKING BREAK
10:40 am
TARGETED LICENSING & ACQUISITIONS
Bing Chen, VP, International BD, AstraZeneca
Miguel Fernández Alcalde, President, EMD Serono
Ansbert Gadicke, Managing Partner, MPM BioImpact
Issei Tsukamoto, SVP, BD, Astellas
Moderator: Raju Prasad, CFO, CRISPR Therapeutics
11:10 am
PLATFORM TO PIPELINE
Greg Geba, SVP, Global Development, Regeneron
Dror Harats, CEO, ImmuneWalk Therapeutics
Barry Ticho, CMO, Stoke Therapeutics
Friedrich von Bohlen, CEO, Molecular Health
Moderator: Cindy Perettie, EVP, Kite Pharma
11:40 am
GUBERNATORIAL KEYNOTE
Maura Healey, Governor, Massachusetts
Moderator: Christoph Westphal, General Partner, Longwood Fund
12:00 pm
NETWORKING LUNCHEON
1:00 pm
DEVELOPING AN EFFECTIVE BOARD
Jeff Cleland, CEO, Ashvattha Therapeutics
John Flavin, Chair, Pyxis Oncology
Rebecca Frey, Venture Partner, RTW Investments
Julie Kampf, CEO, JBK Associates
Moderator: Bill Heiden, Chair, MacroGenics
1:30 pm
NAVIGATING PARTNERSHIPS ACROSS BORDERS
Christian Behrenbruch, CEO, Telix Pharma
Ken Keller, CEO, Daiichi Sankyo, Inc.
Stefan Laukien, CEO, Retroviral Proviromics
Deniz Razon, CBO, Servier Pharmaceuticals
Moderator: Konstantina Katcheves, SVP, Innovative Medicines BD, Teva
2:00 pm
CAPITAL MARKET OUTLOOK
Vinny Jindal, CEO, Secretome Therapeutics
Sabrina Johnson, CEO, Daré Bioscience
Daniel Teper, CEO, NAYA Therapeutics
Moderator: Jason Fenton, Managing Director, Co-Head, ECM, Cantor
2:30 pm
NETWORKING BREAK
3:00 pm
NAVIGATING THE REGULATORY LANDSCAPE
Peter Hutt, former General Counsel, FDA
Shankar Musunuri, CEO, Ocugen
Amit Rakhit, CMO, BlueRock Therapeutics
Janet Woodcock, former Acting Commissioner, FDA
Moderator: Belen Carrillo-Rivas, SVP, Head, Global Regulatory Affairs, Structure Therapeutics
3:30 pm
INNOVATIVE COMMERCIAL MODELS
Robert Blum, CEO, Cytokinetics
Debbie Drane, SVP, Strategic Projects, CSL
Shalabh Gupta, CEO, Unicycive Therapeutics
Tolga Tanguler, CCO, Alnylam
Moderator: Vikram Karnani, CEO, Collegium Pharmaceutical
4:00 pm
MAINTAINING PATIENT-CENTRIC FOCUS
Alisha Alaimo, President & Head, North America, Biogen
Julie Kim, President, US, Takeda
Anne Klibanski, CEO, Mass General Brigham
Matic Meglic, former Global Executive Director, Industry Partnerships, Novartis
Moderator: Gabriele Brambilla, CEO, Alira Health
4:30 pm
ASSESSING INVESTMENT RISK
Ari Brettman, Senior Managing Director, Blackstone
Leland Gershell, Managing Director, Equity Research, Oppenheimer
Ketki Karanam, Partner, Translational Sciences, UPMC Enterprises
Jørgen Søberg Petersen, Senior Partner, Novo Holdings
Moderator: Aleks Radovic-Moreno, Partner, Longwood Fund
7:00 am
REGISTRATION & NETWORKING BREAKFAST
7:30 am
LONGWOOD FUND INTRODUCTION
Aleks Radovic-Moreno, Partner, Longwood Fund
7:45 am
IDENTIFYING NEXT-GENERATION THERAPEUTICS
Keith Flaherty, Director, Clinical Research, Mass General Cancer Center
Ashley Lakner, Head, Oncology Discovery, pRED, Roche
Zdravka Medarova, CSO, TransCode Therapeutics
Ameet Nathwani, CEO, Dewpoint Therapeutics
Moderator: Mat Pletcher, CSO, Weaver
8:15 am
ADVANCES IN CLINICAL TRIALS
Jennifer Chow, CEO, iCell
Stephen Nicholls, CEO, Victorian Heart Hospital
Christophe Quéva, CEO, Egle Therapeutics
Weikang Tao, Corporate VP, President, Global Innovative R&D, Qilu Pharmaceutical
Moderator: Jim Anthony, President & Global Head, Parexel Biotech
8:45 am
SPOTLIGHT ON BIOMEDICAL INNOVATION
Todd Golub, Director & Founding Core Institute Member, Broad Institute of MIT and Harvard
Greg Petsko, Professor, Neurology, Harvard
Matthew Vander Heiden, Director, Koch Institute at MIT
Bob Weinberg, Director, MIT Ludwig Center for Molecular Oncology
Moderator: Lucy Liu, Principal, Longwood Fund
9:15 am
FIRESIDE CHAT
Josh Kraft, President, New England Patriots Foundation
Moderator: Christoph Westphal, General Partner, Longwood Fund
9:30 am
FIRESIDE CHAT: RNAi Revolution: The Alnylam Story
Yvonne Greenstreet, CEO, Alnylam
Phil Sharp, Scientific Founder, Alnylam
Moderator: Christoph Westphal, General Partner, Longwood Fund
9:50 am
NETWORKING BREAK
10:20 am
FIRESIDE CHAT
George Daley, Dean, Harvard Medical School
Sally Kornbluth, President, MIT
Moderator: Christoph Westphal, General Partner, Longwood Fund
10:40 am
MANAGING THE RUNWAY
Nadim Ahmed, CEO, Cullinan Therapeutics
John Climaco, CEO, CNS Pharmaceuticals
Robert Ryan, CEO, Innova Therapeutics
Devyn Smith, CEO, Arbor Bio
Moderator: Joe Stauffer, Chair, BioFuse Medical
11:10 am
SUPPORTING RESEARCH AT THE INTERSECTION OF POLICY & SCIENCE
Congressman Jake Auchincloss, U.S. Representative, Massachusetts
Robert Califf, former Commissioner, FDA
Susan Hockfield, President Emerita, MIT
Moderator: Jeremy Levin, CEO, Ovid Therapeutics
11:40 am
ACCELERATING DRUG DEVELOPMENT
Vanessa Almendro-Navarro, Head, Science & Technology Innovation, Danaher
Ben Liu, CEO, Formation Bio
Marisa Rackley, VP, Study Optimization, Clinical Site Start Up & Site Engagement, Takeda
Roger Tung, former CEO, Concert Pharmaceuticals
Moderator: Yiannis Kiachopoulos, CEO, Causaly
12:10 pm
NETWORKING LUNCHEON
1:00 pm
ADVANCING LATE STAGE ASSETS
Al Beardsley, CEO, Cirius Therapeutics
David Lee, CEO, Servier US
Vikram Sudarsan, CEO, Engrail Therapeutics
James Wooldridge, CMO, Immunitas
Moderator: Teresa Bitetti, President, Global Oncology, Takeda
1:30 pm
ENSURING HEALTH EQUITY AND ACCESS
Aakanksha Khandelwal, Global Commercial Lead, Oncology, Daiichi Sankyo
Nawal Ouzren, CEO, Sensorion
Silvia Taylor, Chief Corporate Affairs & Advocacy Officer, Novavax
Tamar Thompson, VP, Patient Experience & Insights, Alexion; Chair, MassBio
Moderator: Jeb Keiper, Vice Chair, Life Science Cares; former CEO, Nimbus Therapeutics
2:00 pm
FIRESIDE CHAT
Eliav Barr, CMO, Merck
Bill Mezzanotte, Global Head, R&D, CSL
Moderator: Charlotte Moser, CMO, Parexel
2:20 pm
R&D COLLABORATION
Murray Aitken, Executive Director, IQVIA Institute
Brant Binder, President, Bonito Biosciences
Mace Rothenberg, former CMO, Pfizer; President, Museum of Medicine and Biomedical Discovery
Xinchen Wang, CEO, Waypoint Bio
Moderator: Jane Wilkinson, President, CANCollaborate
2:50 pm
ACCELERATING DRUG DISCOVERY
Maurits Geerlings, CEO, Nanocell Therapeutics
Frank Laukien, CEO, Bruker
Frank Nestle, Partner & CEO, Deerfield Discovery and Development
Anaeze Offodile, Chief Strategy Officer, Memorial Sloan Kettering
Moderator: Kara Carter, CEO, Viraccio Therapeutics
3:20 pm
NETWORKING BREAK
3:40 pm
FIRESIDE CHAT
Christophe Weber, CEO, Takeda
Moderator: Seema Kumar, CEO, Cure.
4:00 pm
ECOSYSTEM OF EXTERNAL INNOVATION
Jie D’Elia, CEO, SystImmune
Jennifer Michaelson, CSO, Cullinan Therapeutics
Mike Patten, Chief Strategy Officer, Harbour BioMed
Sam Waksal, CEO, Graviton Corporation
Moderator: Zhen Su, CEO, Marengo Therapeutics
4:30 pm
INVESTMENT OUTLOOK
Eugene Chiu, Senior Partner, Investments, In-Q-Tel
Ann DeWitt, General Partner, Engine Ventures
Mike Ehlers, Entrepreneur Partner, MPM BioImpact
Nandita Shangari, Managing Director, RA Capital
Moderator: Vikas Goyal, Partner, Longwood Fund
5:00 pm
COCKTAIL RECEPTION
Wednesday, June 18
Speaking Faculty
.png)
